FDA Approves First Olmesartan Generics

OCTOBER 27, 2016
Jennifer Barrett, Assistant Editor
The FDA has approved the first generic versions of 4 drugs―Benicar tablets, Benicar HCT tabets, Azor tablets, and Tribenzor tablets―that contain the widely used blood pressure-lowering medication olmesartan medoxomil.
 
The drugs combine olmesartan medoxomil in 1 pill with blood pressure medications amlodipine besylate and hydrochlorothiazide. They are indicated for patients who require multiple blood pressure medications. All 4 drugs are available for oral use in several dosages.
 
Olmesartan medoxomil is an angiotensin-2 receptor blocker that contains a boxed warning about risks of injury or death to a developing fetus during pregnancy.
 
The FDA announced the generics’ approval on October 26.  


SHARE THIS SHARE THIS
0
 

AF Risk Increases with More Pregnancies

One study linked multiple pregnancies to an increased risk of developing atrial fibrillation later in life, and another investigated the association between premature delivery and cardiovascular disease.


 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.